Literature DB >> 32738223

Simultaneous thrombolysis and extracorporeal membrane oxygenation for acute massive pulmonary emboli.

Ting-Wei Lin1, Meng-Ta Tsai2, Yu-Ning Hu2, Yi-Chen Wang2, Jih-Sheng Wen2, Hsuan-Yin Wu3, Chwan-Yau Luo2, Jun-Neng Roan4.   

Abstract

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has been used in patients with circulatory collapse or extremely unstable hemodynamics caused by acute massive pulmonary embolism (PE). The effectiveness of simultaneous thrombolytic therapy has been rarely investigated in these patients after being stabilized with ECMO.
METHODS: From January 2008 to December 2018, consecutive patients with acute massive PE requiring ECMO supported in a tertiary medical center were included for retrospective analysis.
RESULTS: Thirteen patients with PE underwent ECMO implantation and received subsequent thrombolytic therapy as a definite treatment for PE. All patients survived their ECMO courses to a successful de-cannulation, with a mean ECMO support duration of 6.23±4.69 days. Eleven (84.62%) of these patients survived to hospital discharge. All of these survivors were alive during the follow-up, although two (18.2%) of them had permanent dysfunctional neurological complications. Major bleeding complications occurred in four patients (30.77%), while none of them had intracranial hemorrhage. Systemic thrombolysis showed comparable outcomes of catheter-directed thrombolysis in our patients who underwent ECMO.
CONCLUSIONS: Thrombolysis-based therapeutic strategy under ECMO could be a relatively safe and effective definitive treatment for patients with acute massive PE, even for those who were resuscitated. Bleeding complications remain a major concern and should be monitored and managed immediately.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32738223     DOI: 10.1016/j.athoracsur.2020.05.155

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Prothymosin α Gene Transfer Modulates Myocardial Remodeling after Ischemia-Reperfusion Injury.

Authors:  Ai-Li Shiau; Shih-Yuan Fang; Chih-Hsin Hsu; Meng-Hsuan Chiu; Chen-Fuh Lam; Chao-Liang Wu; Jun-Neng Roan
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.